CDC Travel Advisory Highlights Global Dengue Surge Risks

With dengue cases reaching unprecedented levels worldwide, the U.S. Centers for Disease Control and Prevention has issued a global travel notice urging international travelers to take stronger precautions against mosquito-borne illnesses.

A Global Dengue Surge Reshaping Travel Risk

Publicly available information from international health agencies shows that dengue transmission has intensified across the tropics and subtropics, with ripple effects for travelers from North America and Europe. World Health Organization data indicate that 2024 marked the highest global dengue burden ever recorded, with cases reported in more than 100 countries, and outbreaks spanning Latin America, the Caribbean, Asia, Africa and parts of the Pacific.

Regional reports from the Americas describe record-breaking seasons, with millions of suspected infections and thousands of severe cases and deaths. Brazil, Argentina and several Caribbean destinations have all documented large-scale outbreaks across consecutive seasons, signaling that dengue is becoming a year-round threat rather than a strictly seasonal disease. Similar patterns have been described in parts of South and Southeast Asia, where dengue has long been endemic but is now resurging in both urban and tourist areas.

At the same time, European surveillance data show a growing number of imported dengue infections in returning travelers and a rising tally of locally acquired cases in countries such as France, Italy, Portugal and Spain. While dengue is still not considered endemic across most of mainland Europe, health agencies note that warmer summers and expanding populations of Aedes mosquitoes are increasing the likelihood that travelers could encounter the virus closer to home.

This global backdrop of sustained high transmission underpins the CDC’s decision to issue a worldwide Level 1 travel notice for dengue, advising travelers to “practice usual precautions” but with an emphasis on more consistent mosquito bite prevention and greater clinical awareness of dengue symptoms in recent travelers.

Inside the CDC Global Dengue Travel Notice

According to CDC travel health resources and summary presentations published by U.S. state and local health departments, the agency introduced a global Level 1 dengue travel notice in mid 2024. The advisory does not impose travel restrictions, but it signals that dengue activity is sufficiently widespread that all international travelers to risk areas should be alerted and better prepared.

The notice highlights several key concerns. First, it notes the record number of dengue cases across the Americas and other regions, including repeated outbreaks in popular destinations such as Brazil, Mexico, Puerto Rico and several Caribbean islands. Second, it underscores the potential for travelers to bring the virus back to areas of the United States where Aedes mosquitoes are established, particularly parts of Florida, Texas, the Gulf Coast and Hawaii, increasing the risk of limited local transmission.

CDC health alert updates emphasize that U.S. clinicians are seeing more dengue infections among travelers and that multiple virus serotypes, including DENV 4, have been detected in recent imported cases. This pattern raises concern because infections with a second, different serotype can be associated with higher risk of severe disease. The agency has therefore updated its testing recommendations, encouraging more routine dengue testing in people who develop acute fever after returning from affected areas.

In practical terms, the global travel notice serves as a broad warning that dengue risk is no longer confined to a handful of destinations. Travelers planning trips to Latin America, the Caribbean, South and Southeast Asia, some parts of Africa and the Pacific are advised to check destination specific health pages, confirm whether dengue vaccination is recommended for their situation, and factor mosquito protection into every stage of their travel planning.

Rising Mosquito-Borne Threats Beyond Dengue

While dengue is at the center of the current CDC advisory, intelligence from European and national public health agencies shows that it is part of a wider mosaic of mosquito-borne threats. West Nile virus, chikungunya and Zika virus continue to circulate in various regions, and Europe has documented hundreds of locally acquired West Nile infections and an increasing number of locally transmitted dengue cases in recent seasons.

Reports from the European Centre for Disease Prevention and Control describe how the Aedes albopictus mosquito, a key vector for dengue, chikungunya and Zika, has established self sustaining populations across a growing list of European countries. As the mosquito’s range expands north and west, health authorities anticipate more frequent outbreaks seeded by infected travelers returning from tropical regions.

Travel surveillance data from the United Kingdom and other European states show that imported dengue cases have reached record highs among returning travelers, with sizable proportions linked to trips to South and Southeast Asia, as well as the Caribbean and Central and South America. Similar patterns are emerging in North America, where U.S. territories in the Caribbean remain endemic for dengue and mainland states record sporadic local transmission episodes when infected travelers arrive during peak mosquito season.

Climate-related factors are increasingly cited in public analyses as amplifying these risks. Warmer temperatures, altered rainfall patterns and urbanization can extend mosquito breeding seasons and create new habitats in both tropical and temperate zones. For travelers, this means that the geography and timing of mosquito-borne disease risk are shifting, and traditional assumptions about “low season” safety may no longer hold.

How Travelers Can Respond to the Elevated Risk

CDC guidance on preventing mosquito bites while traveling stresses that personal protection remains the primary line of defense, especially in regions where dengue and other arboviruses are circulating. Travelers are advised to use insect repellents that contain ingredients such as DEET, picaridin, IR3535 or oil of lemon eucalyptus, applying them to exposed skin according to product instructions.

Clothing choices can also reduce risk. Lightweight, loose fitting long sleeves, long pants and socks create a physical barrier against mosquito bites. Treating clothing, shoes and gear with a permethrin based product before departure can provide additional protection, particularly for travelers who expect to spend time outdoors at dawn and dusk when Aedes mosquitoes most often bite. Staying in accommodations with air conditioning, intact window screens or bed nets further lowers exposure.

Public information from travel clinics and health agencies also encourages travelers to schedule a pre travel health consultation four to six weeks before departure. During this visit, clinicians can review planned destinations and activities, discuss whether dengue vaccination is appropriate based on age, prior infection history and vaccine availability, and ensure that routine and recommended vaccines are up to date. Travelers with underlying health conditions, pregnant travelers and families with young children are often advised to be especially cautious about destinations with active dengue transmission.

Equally important is post travel awareness. Many health agencies urge anyone who develops fever, headache, muscle and joint pain, rash or other compatible symptoms within two weeks of returning from a dengue affected area to seek medical care and mention their recent travel history. Prompt diagnosis not only improves clinical care but also helps prevent ongoing transmission if local mosquitoes are present.

Planning Future Trips in a Changing Disease Landscape

The CDC’s global dengue travel notice comes at a time when international travel has largely rebounded and many destinations that experienced severe outbreaks remain high on travelers’ wish lists. As a result, risk management is shifting from avoiding specific countries to taking layered precautions nearly anywhere dengue is circulating.

Travel risk assessments now increasingly incorporate local outbreak information, seasonal patterns and environmental conditions. For example, travelers may choose to adjust trip timing to avoid peak rainy seasons in certain regions, select accommodations with robust mosquito control measures, or build extra time into itineraries in case illness disrupts activities.

Travel industry observers note that some tour operators and hotels in high risk regions are investing more in visible mosquito control, such as regular property inspections, larvicide use and guest education about repellents and protective clothing. Airlines and cruise lines are also updating health advisories in pre departure materials, reflecting the new prominence of dengue and related diseases in global travel health discussions.

For individual travelers, the core message from current guidance is to stay informed and prepared rather than alarmed. By monitoring official travel health notices, consulting healthcare professionals before and after trips, and making mosquito protection as routine as packing a passport, travelers can continue to explore dengue affected regions while meaningfully reducing their risk.